DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Tagliaferri A, Matichecchia A, Rivolta GF. et al.
Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.
Blood Transfus 2019; . [Epub ahead of print]
DOI: 10.2450/2019.0220-19.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.